Cargando…
The Effect of Trimebutine and/or Helicobacter pylori Eradication on the Gastroesophageal Reflux Disease, Irritable Bowel Syndrome, and Functional Dyspepsia Overlapping Disorders
Autores principales: | Kountouras, Jannis, Gavalas, Emmanouel, Doulberis, Michael, Polyzos, Stergios A, Papaefthymiou, Apostolis, Touloumtzi, Maria, Vardaka, Elisabeth, Kountouras, Konstantinos, Papanikolopoulou, Katerina, Katsinelos, Panagiotis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society of Neurogastroenterology and Motility
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6657919/ https://www.ncbi.nlm.nih.gov/pubmed/31177649 http://dx.doi.org/10.5056/jnm19033 |
Ejemplares similares
-
Gastroesophageal reflux disease, irritable bowel syndrome and functional dyspepsia as overlapping conditions: focus on effect of trimebutine
por: Kountouras, Jannis, et al.
Publicado: (2019) -
Impact of Helicobacter pylori-related Metabolic Syndrome and Gastroesophageal Reflux Disease on the Risk of Acute Myocardial Infarction
por: Kountouras, Jannis, et al.
Publicado: (2021) -
Trimebutine Maleate Monotherapy for Functional Dyspepsia: A Multicenter, Randomized, Double-Blind Placebo Controlled Prospective Trial
por: Kountouras, Jannis, et al.
Publicado: (2020) -
Helicobacter pylori infection and gastroesophageal reflux disease - Barrett’s esophagus sequence “dilemma”
por: Kountouras, Jannis, et al.
Publicado: (2015) -
National consensus on Helicobacter pylori infection: the next-day challenge
por: Papaefthymiou, Apostolis, et al.
Publicado: (2020)